 |
Allergopharma
The allergy and specific immunotherapy specialist
Allergopharma is an internationally operating pharmaceutical company specialized in research, production and distribution of preparations for in vivo diagnosis and treatment - specific immunotherapy (SIT) - of type 1 allergies.
Allergies caused by grass pollen, tree pollen (e.g. birch pollen), house dust mite allergens or mould spores are now among the most prevalent of all diseases and affect 20-35% of people worldwide. Subcutaneous specific immunotherapy (SCIT) is widely accepted as the only causal treatment for allergies that can prevent the allergic march to asthma and new allergies/sensitizations (long-term efficacy).
...read more
The EAACI annual Congress this year takes place in Geneva, from June 16-20. In an own symposium Allergopharma will present ... more
|
|
|
|
|
|
The 11th Award was presented by the Past President of the European Academy, Professor Roy Gerth van Wijk, to Dr. Denis Bedoret in Istanbul, Turkey ... more
|
|
|
|
|
|
|
|
Group | Copyright © 2010 Allergopharma. All right reserved |
Terms of use
| This website is not directed at German users. For the German website please
click here.
